Polypid

Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)

placePetah Tikva, Central District, Israel calendar_todayFounded 2008 groups69 employees language polypid.com

Innovation

15 patent families (7 granted) — focus: Human necessities; filing pace slowing. Cited 911 times.

YearFilings
20156
20168
20175
20184
20193
20204
20213
20223
20235
20242
20252
20261

Social engagement

Social engagement: 3.5K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Shavit Capital, Aurum Ventures.

Investor typeCountShare
Venture capital563%
Private equity225%
Other / undisclosed113%

Recent activity

2 Jun 2026
Milestone
regulatory
1 Jun 2026
Product launch
D-PLEX100
28 Apr 2026
Event
Surgical Infection Society 2026 Annual Meeting
Coming soon